Back
Omnicell 10K Form
Sell
36
OMCL
Omnicell
Last Price:
56.33
Seasonality Move:
13.86%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-07-31 | 10Q | OMCL/Omnicell Quarterly |
| 2020-05-08 | 10Q | OMCL/Omnicell Quarterly |
| 2020-02-26 | 10K | OMCL/Omnicell Annual |
| 2019-11-01 | 10Q | OMCL/Omnicell Quarterly |
| 2019-08-02 | 10Q | OMCL/Omnicell Quarterly |
| 2019-05-03 | 10Q | OMCL/Omnicell Quarterly |
Receive OMCL News And Ratings
See the #1 stock for the next 7 days that we like better than OMCL
OMCL Financial Statistics
Sales & Book Value
| Annual Sales: | $1.3B |
|---|---|
| Cash Flow: | $64.92M |
| Price / Cash Flow: | 150.42 |
| Annual Sales: | $25.26 |
| Price / Book: | 2.21 |
Profitability
| EPS (TTM): | 0.10000 |
|---|---|
| Net Income (TTM): | $5.65M |
| Gross Margin: | $588.99M |
| Return on Equity: | 0.51% |
| Return on Assets: | 0.26% |
Omnicell Earnings Forecast
Key Omnicell Financial Ratios
- The Gross Profit Margin over the past 23 years for OMCL is 45.45%.
- The Selling, General & Administrative Expenses for OMCL have been equal to 37.53% of Gross Profit Margin.
- The Research & Development expenses have been 8.10% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of OMCL is 0.44% of Total Revenues.
- Per Share Earnings over the last 23 years have been positive in 15 years.
Omnicell Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Information Services |
| Sector: | Healthcare |
| Current Symbol: | OMCL |
| CUSIP: | 68213N |
| Website: | omnicell.com |
Debt
| Debt-to-Equity Ratio: | 0.5 |
|---|---|
| Current Ratio: | 2.06 |
| Quick Ratio: | 1.5 |
Price-to-Earnings
| Trailing P/E Ratio: | 462.67 |
|---|---|
| Forward P/E Ratio: | 0 |